Despite its advantages, SBDD faces several challenges: - Structural Flexibility: Enzymes are not rigid structures; their active sites can change shape, complicating the design process. - Binding Affinity: Predicting the exact binding affinity of a drug molecule to an enzyme is still an area of active research. - Side Effects: Drugs designed to inhibit a specific enzyme might also affect other enzymes, leading to unwanted side effects.
